KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks
$6.20
+6.08 (+5,199.15%)
At Close: Apr 26, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile
Date Action Amount Person Type
Apr 16, 2024 Buy 413 507 Fortress Biotech, Inc. COMMON STOCK, PAR VALUE $0.0001
Jan 02, 2024 Buy 2 101 496 Fortress Biotech, Inc. COMMON STOCK, PAR VALUE $0.0001
Dec 11, 2023 Sell 264 000 Davidow Robert L Common Stock
Dec 11, 2023 Sell 126 000 Davidow Robert L Common Stock
Dec 11, 2023 Sell 128 000 Davidow Robert L Common Stock
Dec 11, 2023 Sell 20 000 Davidow Robert L Common Stock
Dec 11, 2023 Sell 61 000 Davidow Robert L Common Stock
Dec 11, 2023 Sell 18 000 Davidow Robert L Common Stock
Oct 31, 2023 Buy 0 Davidow Robert L Common Stock
Oct 31, 2023 Buy 0 Davidow Robert L Common Stock
Oct 31, 2023 Buy 0 Davidow Robert L Common Stock
Oct 31, 2023 Buy 0 Davidow Robert L Common Stock
Oct 31, 2023 Buy 0 Davidow Robert L Common Stock
Oct 31, 2023 Buy 0 Davidow Robert L Common Stock
Oct 31, 2023 Buy 0 Davidow Robert L Common Stock
Sep 08, 2023 Buy 348 675 Rosenwald Lindsay A Md Common Stock
Sep 08, 2023 Buy 418 410 Fortress Biotech, Inc. Common Stock
Jun 30, 2023 Buy 100 000 Charles Faith L. Employee stock option (right to buy)
Jun 30, 2023 Buy 250 000 Jin David Employee stock option (right to buy)
Jun 30, 2023 Buy 100 000 Rosenwald Lindsay A Md Employee stock option (right to buy)
Jun 30, 2023 Buy 100 000 Kranzler Jay D Employee stock option (right to buy)
Jun 30, 2023 Buy 100 000 Oltmans Curtis Gale Employee stock option (right to buy)
Jun 30, 2023 Buy 100 000 Herskowitz Neil Employee stock option (right to buy)
Jun 29, 2023 Buy 800 000 Maclean Alexandra Employee stock option (right to buy)
Mar 31, 2023 Buy 52 419 Fortress Biotech, Inc. COMMON STOCK, PAR VALUE $0.0001
Jan 03, 2023 Buy 231 316 Fortress Biotech, Inc. COMMON STOCK, PAR VALUE $0.0001
Dec 31, 2022 Buy 90 909 Fortress Biotech, Inc. COMMON STOCK, PAR VALUE $0.0001
Oct 11, 2022 Sell 388 888 Invagen Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share
Aug 01, 2022 Buy 0 Maclean Alexandra
May 16, 2022 Buy 0 Charles Faith L.
May 11, 2022 Buy 0 Jin David
Dec 17, 2021 Buy 20 000 Kranzler Jay D Common Stock
Dec 17, 2021 Buy 49 020 Kranzler Jay D Common Stock
Dec 17, 2021 Buy 20 000 Herskowitz Neil Common Stock
Dec 17, 2021 Buy 49 020 Herskowitz Neil Common Stock
Dec 17, 2021 Buy 49 020 Oltmans Curtis Gale Common Stock
Dec 17, 2021 Buy 411 616 Lu Lucy Common Stock
Dec 17, 2021 Buy 100 505 Vazzano Joseph Walter Common Stock
Sep 15, 2021 Sell 7 160 Vazzano Joseph Walter Common Stock
May 06, 2021 Buy 2 500 Herskowitz Neil Common Stock
Apr 01, 2021 Buy 0 Oltmans Curtis Gale
Aug 20, 2020 Sell 3 840 Vazzano Joseph Walter Common Stock
Jun 16, 2020 Buy 10 000 Kranzler Jay D Common Stock
Jun 16, 2020 Buy 10 000 Herskowitz Neil Common Stock
Mar 10, 2020 Buy 1 889 Vazzano Joseph Walter Common Stock
Mar 09, 2020 Buy 100 Vazzano Joseph Walter Common Stock
Mar 09, 2020 Buy 1 400 Vazzano Joseph Walter Common Stock
Feb 27, 2020 Buy 2 400 Herskowitz Neil Common Stock
Feb 26, 2020 Buy 161 Herskowitz Neil Common Stock
Feb 25, 2020 Buy 1 200 Vazzano Joseph Walter Common Stock
Feb 25, 2020 Buy 10 000 Herskowitz Neil Common Stock
Feb 12, 2020 Buy 22 727 Vazzano Joseph Walter Restricted Stock Units
Feb 12, 2020 Buy 110 959 Lu Lucy Restricted Stock Units
Sep 12, 2019 Buy 16 000 Ingram Elizabeth Garrett Common Stock
Aug 27, 2019 Buy 10 000 Kranzler Jay D Common Stock
Aug 27, 2019 Buy 10 000 Herskowitz Neil Common Stock
Aug 09, 2019 Sell 2 375 Vazzano Joseph Walter Common Stock
Aug 08, 2019 Sell 2 313 Vazzano Joseph Walter Common Stock
Aug 01, 2019 Buy 0 Ingram Elizabeth Garrett
Jun 18, 2019 Buy 2 000 Herskowitz Neil Common Stock
Jun 17, 2019 Buy 3 000 Herskowitz Neil Common Stock
Jun 03, 2019 Buy 27 778 Vazzano Joseph Walter Restricted Stock Units
Jun 03, 2019 Buy 135 617 Lu Lucy Restricted Stock Units
Apr 30, 2019 Buy 0 Moore Thomas Gregory
Apr 15, 2019 Buy 1 000 Herskowitz Neil Common Stock
Mar 29, 2019 Buy 1 400 Herskowitz Neil Common Stock
Mar 28, 2019 Buy 600 Herskowitz Neil Common Stock
Feb 25, 2019 Buy 5 000 Herskowitz Neil Common Stock
Feb 08, 2019 Buy 0 Invagen Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share
Feb 08, 2019 Buy 0 Invagen Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share
Feb 08, 2019 Buy 0 Invagen Pharmaceuticals, Inc. Class A Preferred Stock, par value $0.0001 per share
Feb 08, 2019 Buy 135 617 Invagen Pharmaceuticals, Inc. Restricted Stock Units
Feb 08, 2019 Buy 0 Gogtay Jaideep Ashok
Feb 08, 2019 Buy 0 Saxena Nishant
Feb 05, 2019 Buy 1 850 Herskowitz Neil Common Stock
Feb 04, 2019 Buy 7 000 Herskowitz Neil Common Stock
Jan 30, 2019 Buy 650 Herskowitz Neil Common Stock
Jan 29, 2019 Buy 8 553 Herskowitz Neil Common Stock
Jan 28, 2019 Buy 1 447 Herskowitz Neil Common Stock
Dec 10, 2018 Buy 5 000 Paley Jeffrey Common Stock
Dec 03, 2018 Buy 10 000 Paley Jeffrey Common Stock
Aug 07, 2018 Buy 30 000 Vazzano Joseph Walter Common Stock
Aug 07, 2018 Buy 250 000 Lu Lucy Common Stock
Aug 07, 2018 Buy 14 663 Rosenwald Lindsay A Md Common Stock
Aug 07, 2018 Buy 14 663 Herskowitz Neil Common Stock
Aug 07, 2018 Buy 14 663 Kranzler Jay D Common Stock
Aug 07, 2018 Buy 10 000 Reines Scott Common Stock
Aug 07, 2018 Buy 14 663 Weiss Michael S Common Stock
Aug 07, 2018 Buy 14 663 Paley Jeffrey Common Stock
Aug 07, 2018 Buy 14 663 Samad Akhtar Common Stock
Jun 28, 2018 Buy 1 351 Vazzano Joseph Walter Common Stock
Jun 14, 2018 Buy 5 000 Lu Lucy Common Stock
Jun 08, 2018 Buy 5 234 Rosenwald Lindsay A Md Common Stock
Jun 08, 2018 Buy 5 234 Rosenwald Lindsay A Md Common Stock
Jun 07, 2018 Buy 14 800 Rosenwald Lindsay A Md Common Stock
Jun 06, 2018 Buy 9 100 Rosenwald Lindsay A Md Common Stock
Jun 05, 2018 Buy 8 400 Rosenwald Lindsay A Md Common Stock
Jun 04, 2018 Buy 3 800 Rosenwald Lindsay A Md Common Stock
Jun 01, 2018 Buy 8 666 Rosenwald Lindsay A Md Common Stock
Apr 25, 2018 Buy 1 000 Herskowitz Neil Common Stock
JSON CSV
INSIDER POWER
71.487
Last 100 transactions
Buy: 6 902 324 | Sell: 1 021 576 (Shares)

Based on the 100 latest insides trades, we have calculated the insider power to be positive at a ratio of 71.487.

In total, the insiders bought 6 902 324 and sold 1 021 576 ATXI shares in the last 100 trades.

Click to get the best stock tips daily for free!

About Avenue Therapeutics, Inc.

Avenue Therapeutics. Avenue Therapeutics, Inc., a specialty pharmaceutical company, develops and commercializes products primarily for use in the acute/intensive care hospital setting. Its product candidate is intravenous Tramadol, a synthetic dual-acting opioid, which is in Phase III clinical trials for the treatment of post-operative acute pain. The company was incorporated in 2015 and is based in New York, New York.... ATXI Profile

Golden Star

Ticker Date Change Price
DHT Apr 24 2.04% $11.28
MLI Apr 19 9.66% $52.28
LPLA Apr 19 1.42% $262.59
DOOR Apr 18 0.167% $131.39
LNG Apr 17 1.49% $156.81
FCN Apr 16 1.80% $207.62
ELV Apr 16 5.97% $506.97
AKR Apr 05 4.78% $16.53
ITCI Apr 05 7.04% $68.44
VSTS Apr 04 0.425% $18.82
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT